Patents by Inventor Jens Riedner

Jens Riedner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis scheme for lacosamide
    Patent number: 8809585
    Abstract: The present invention is concerned with an improved method of producing (R)-2-acetamido-N-benzyl-3-methoxypropionamide (lacosamide) comprising the 0-methylation of a compound of formula (I) to produce a compound of formula (II) in a single step reaction.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: August 19, 2014
    Assignee: UCB Pharma GmbH
    Inventors: Jens Riedner, Gavin Dunne
  • Polymorphic form of rotigotine and process for production
    Patent number: 8592477
    Abstract: The present invention relates to a novel polymorphic form of Rotigotine characterized by at least one of the following X-ray powder diffraction peaks: 12.04, 13.68, 17.72 and 19.01±0.2 (°2?), measured with a Cu—K? irradiation (1.54060), and a process for production thereof, which is useful for the manufacture of a stable medicament for treating or alleviating symptoms of Parkinson's Disease and other dopamine-related disorders.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: November 26, 2013
    Assignee: UCB Pharma GmbH
    Inventors: Hans-Michael Wolff, Luc Quere, Jens Riedner
  • Polymorphic form of rotigotine and process for production
    Patent number: 8232414
    Abstract: The present invention relates to a novel polymorphic form of rotigotine characterized by at least one of the following powder X-ray diffraction peaks: 12.04, 13.68, 17.72 and 19.01±0.2 (° 2?), measured with a Cu—K? irradiation (1.54060 ?), and a process for production thereof, which is useful for the manufacture of a stable medicament for treating or alleviating symptoms of Parkinson's disease and other dopamine-related disorders.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: July 31, 2012
    Assignee: UCB Pharma GmbH
    Inventors: Hans-Michael Wolff, Luc Quere, Jens Riedner
  • SYNTHESIS SCHEME FOR LACOSAMIDE
    Publication number: 20110130350
    Abstract: The present invention is concerned with an improved method of producing (R)-2-acetamido-N-benzyl-3-methoxypropionamide (lacosamide) comprising the 0-methylation of a compound of formula (I) to produce a compound of formula (II) in a single step reaction.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 2, 2011
    Applicant: UCB PHARMA GMBH
    Inventors: Jens Riedner, Gavin Dunne
  • Synthesis scheme for lacosamide
    Patent number: 7884134
    Abstract: The present invention is concerned with an improved method of producing (R)-2-acetamido-N-benzyl-3-methoxypropionamide (lacosamide) comprising the O-methylation of a compound of formula I to produce a compound of formula II in a single step reaction.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: February 8, 2011
    Assignee: UCB Pharma GmbH
    Inventors: Jens Riedner, Gavin Dunne
  • NOVEL POLYMORPHIC FORM OF ROTIGOTINE AND PROCESS FOR PRODUCTION
    Publication number: 20100311806
    Abstract: The present invention relates to a novel polymorphic form of Rotigotine characterized by at least one of the following X-ray powder diffraction peaks: 12.04, 13.68, 17.72 and 19.01±0.2 (°2?), measured with a Cu—K?irradiation (1.54060), and a process for production thereof, which is useful for the manufacture of a stable medicament for treating or alleviating symptoms of Parkinson's Disease and other dopamine-related disorders.
    Type: Application
    Filed: November 25, 2008
    Publication date: December 9, 2010
    Applicant: UCB PHARMA GMBH
    Inventors: Hans-Michael Wolff, Luc Quere, Jens Riedner
  • NOVEL POLYMORPHIC FORM OF ROTIGOTINE AND PROCESS FOR PRODUCTION
    Publication number: 20090143460
    Abstract: The present invention relates to a novel polymorphic form of rotigotine characterized by at least one of the following powder X-ray diffraction peaks: 12.04, 13.68, 17.72 and 19.01±0.2 (° 2?), measured with a Cu—K? irradiation (1.54060 ?), and a process for production thereof, which is useful for the manufacture of a stable medicament for treating or alleviating symptoms of Parkinson's disease and other dopamine-related disorders.
    Type: Application
    Filed: November 26, 2008
    Publication date: June 4, 2009
    Inventors: Hans-Michael Wolff, Luc Quere, Jens Riedner
  • Synthesis Scheme for Lacosamide
    Publication number: 20080027137
    Abstract: The present invention is concerned with an improved method of producing (R)-2-acetamido-N-benzyl-3-methoxypropionamide (lacosamide) comprising the O-methylation of a compound of formula I to produce a compound of formula II in a single step reaction.
    Type: Application
    Filed: September 30, 2005
    Publication date: January 31, 2008
    Applicant: SCHWARZ PHARMA AG
    Inventors: Jens Riedner, Gavin Dunne